FGF2 and Alzheimer disease: PEG–PLGA (PEG–poly(lactic-co-glycolic acid)) nanoparticles have demonstrated effectiveness in delivering basic fibroblast growth factor (bFGF) directly to the brain for treatment of Alzheimer’s disease.